Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | -9.98% | -.--% | +29.82% |
05-31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
05-31 | Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial | CI |
- Stock Market
- Equities
- HNSA Stock
- HNSBF Stock
- News Hansa Biopharma AB